Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Aricò, Arianna ^a   Ferraresso, Serena ^a   Bresolin, Silvia ^a   Marconato, Laura ^b   Comazzi, Stefano ^c   Kronnie, Geertruy Te ^a   Aresu, Luca ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clinica Veterinaria dell'Orologio and Centra Oncologico Veterinario   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; LACTATE DEHYDROGENASE; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANINE DIFFUSE LARGE B CELL LYMPHOMA; CHROMOSOME 13; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DOG DISEASE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; LARGE CELL LYMPHOMA; NONHUMAN; PRIMARY TUMOR; VACCINATION; ANIMAL; CHROMOSOME ABERRATION; DOG; GENETICS; HUMAN; METABOLISM; PROGNOSIS;

ANIMALS; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DOGS; GENETICS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; METABOLIC NETWORKS AND PATHWAYS; PROGNOSIS;

EID: 84910003199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111817     Document Type: Article

References (39)

1. Aresu L, Martini V, Rossi F, Vignoli M, Sampaolo M, et al. (2013) Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation. Vet Comp Oncol: doi:10.1111/vco.12048.
2. Mudaliar MA, Haggart RD, Miele G, Sellar G, Tan KA, et al. (2013) Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL). PLoS One 8(9): e72591.
3. Richards KL, Motsinger-Reif AA, Chen HW, Fedoriw Y, Fan C, et al. (2013) Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res 73(16): 5029-39.
4. Marconato L, Frayssinet P, Rouquet N, Comazzi S, Leone VF, et al. (2014) Randomized, Placebo-Controlled, Double-Blinded Chemoimmunotherapy Clinical Trial in a Pet Dog Model of Diffuse Large B-cell Lymphoma. Clin Cancer Res 20(3): 668-77.
5. Tirado CA, Chen W, García R, Kohlman KA, Rao N (2012) Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature. J Hematol Oncol 5: 54.
6. Thomas R, Seiser EL, Motsinger-Reif A, Borst L, Valli VE, et al. (2011) Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas. Leuk Lymphoma 52(7): 1321-35.
7. Kanamori M, Sano A, Yasuda T, Hori T, Suzuki K (2012) Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors. J Exp Clin Cancer Res 31: 100.
8. Shi ZZ, Zhang YM, Shang L, Hao JJ, Zhang TT, et al. (2012) Genomic profiling of rectal adenoma and carcinoma by array-based comparative genomic hybridization. BMC Med Genomics 5: 52.
9. Hashemi J, Fotouhi O, Sulaiman L, Kjellman M, Höög A, et al. (2013) Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization. BMC Cancer 13: 505.
10. Romania P, Castellano A, Surace C, Citti A, De Ioris MA, et al. (2013) Highresolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma. PLoS One 8(10): e78481.
11. Wang L, Rao M, Fang Y, Hameed M, Viale A, et al. (2013) A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation. J Mol Diagn 15(5): 581-91.
12. Martínez-Climent JA, Fontan L, Fresquet V, Robles E, Ortiz M, et al, (2010) Integrative oncogenomic analysis of microarray data in hematologic malignancies. Methods Mol Biol 576: 231-77.
13. Landau DA, Carter SL, Getz G, Wu CJ (2014) Clonal evolution in hematological malignancies and therapeutic implications. Leukemia 28(1): 34-43.
14. Andre F, Job B, Dessen P, Tordai A, Michiels S, et al. (2009) Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15(2): 441-51.
15. Tagawa H, Tsuzuki S, Suzuki R, Karnan S, Ota A, et al. (2004) Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res 64(17): 5948-55.
16. Tagawa H, Suguro M, Tsuzuki S, Matsuo K, Karnan S, et al. (2005) Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 106(5): 1770-7.
17. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, et al. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105(36): 13520-5.
18. Takeuchi I, Tagawa H, Tsujikawa A, Nakagawa M, Katayama-Suguro M, et al. (2009) The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis. Haematologica 94(1): 61-9.
19. Kreisel F, Kulkarni S, Kerns RT, Hassan A, Deshmukh H, et al. (2011) High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immunochemotherapy. Cancer Genet 204(3): 129-37.
20. Marconato L (2011) The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects. Vet J 188(1): 34-8.
21. Ristow M (2006) Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care 9(4): 339-45.
22. Zheng J (2012) Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation. Oncol Lett 4(6): 1151-1157.
23. Bauer TR Jr, McDermid HE, Budarf ML, Van Keuren ML, Blomberg BB (1993) Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2. Immunogenetics 38(6): 387-99.
24. Küppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20(40): 5580-94.
25. de Jong D, Voetdijk BM, Van Ommen GJ, Kluin-Nelemans JC, Beverstock GC, et al. (1989) Translocation t(14; 18) in B cell lymphomas as a cause for defective immunoglobulin production. J Exp Med 169(3): 613-24.
26. Grier DD, Al-Quran SZ, Cardona DM, Li Y, Braylan RC (2012) Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasia. Int J Clin Exp Pathol 5(2): 110-8.
27. Pedersen MØ, Gang AO, Poulsen TS, Knudsen H, Lauritzen AF, et al. (2014) MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations. Eur J Haematol. 92(1): 42-8.
28. Capello D, Cerri M, Muti G, Lucioni M, Oreste P, et al. (2006) Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders. Hematol Oncol 24(4): 212-9.
29. Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, et al. (2013) Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol: doi:10.1038/ modpathol.2013.214.
30. Maekawa M, Taniguchi T, Ishikawa J, Sugimura H, Sugano K, et al. (2003) Promoter hypermethylation in cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes 1-4. Clin Chem 49(9): 1518-20.
31. Zha X, Wang F, Wang Y, He S, Jing Y, et al. (2011) Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 71(1): 13-8.
32. Marconato L, Crispino G, Finotello R, Mazzotti S, Zini E, et al. (2010) Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma. J Am Vet Med Assoc 236(9): 969-74.
33. Paugh BS, Zhu X, Qu C, Endersby R, Diaz AK, et al. (2013) Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 73(20): 6219-29.
34. Schmitt-Graeff AH, Erben P, Schwaab J, Vollmer-Kary B, Metzgeroth G, et al. (2014) The FIP1L1-PDGFRA fusion gene and the KIT D816 V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia. Blood 123(4): 595-7.
35. Zong L, Chen P (2014) Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World J Surg Oncol 12(1): 71.
36. Aricò A, Guadagnin E, Ferraresso S, Gelain ME, Iussich S, et al. (2014) Plateletderived Growth Factors and Receptors in Canine Lymphoma. J Comp Pathol. doi:10.1016/j.jcpa.2014.07.001.
37. Wang X, Li X, Fan F, Jiao S, Wang L, et al. (2012) PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis 33(11): 2228-35.
38. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381): 306-13.
39. Manne J, Mastrangelo MJ, Sato T, Berd D (2002) TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine. J Immunol 69(6): 3407-12.